London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Lakmal Jayasinghe
)
- Job title
- Institution
- Chief Scientific Officer, Oxford Nanopore Technologies
- Biography
Dr Lakmal Jayasinghe is the Chief Scientific Officer at Oxford Nanopore Technologies, where he leads the company's scientific vision, driving groundbreaking research and development to advance innovation in nanopore sequencing and its transformative applications.
Before joining Oxford Nanopore in 2006, Lakmal completed his PhD in chemical biology at the University of Oxford, where he was a member of the Hagan Bayley group. His research focused on the study and engineering of nanopores using genetic and chemical approaches, providing him with a deep understanding of nanopore technology. During his tenure at Oxford Nanopore, the company has achieved unprecedented advancements in sequencing accuracy, throughput, and versatility, enabling global researchers to explore applications spanning genomics, transcriptomics, and epigenetics. Lakmal has also championed advancements in direct RNA sequencing, revolutionising the study of native RNA molecules and their modifications, both in academic research and the biopharma industry. During his time with Oxford Nanopore, Lakmal has held several leadership positions, including Senior Scientist, Principal Scientist, and Vice President, where he has led interdisciplinary R&D teams in biologics.
Dr Jayasinghe actively collaborates with worldwide academic partners to ensure that Oxford Nanopore leverages the best biological components and chemistries in its platforms. He actively supports initiatives in education, skill development, and partnerships aimed at democratising access to sequencing technology. A strong advocate for multiomics approaches, Lakmal envisions a future where Oxford Nanopore technology seamlessly integrates genomics, transcriptomics, proteomics, and metabolomics to tackle complex biological questions and improve human health.
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.